Winter Park 407-337-3000
The Villages 352-441-2000
Ver en Español

Studies

Join a study.
Help find a cure.

Every medical breakthrough we celebrate and benefit from is because of volunteers just like you. Everyday people who say “yes” to participating in clinical trials are changing the world for the better.

Explore our open studies — each one represents an opportunity to help build healthier futures.

Select a condition
to view the relevant open studies

“AACM” Alzheimer’s Prevention

If you're worried that your memory might start fading, then joining an Alzheimer's prevention study might be a great option for you. It might just help future generations too. This study examines whether a new drug may help to slow or prevent the onset of Alzheimer's disease in those with...

Preliminary Qualifications

  • 65-80 years of age.
  • Normal memory and thinking.
  • Blood test (given at Charter) indicates elevated risk of developing Alzheimer's.

“Prevención del Alzheimer “AHEAD

Si le preocupa que su memoria empiece a fallar, apuntarse a un estudio de prevención del Alzheimer puede ser una gran opción para usted. También podría ayudar a las generaciones futuras. Este estudio examina si un nuevo fármaco puede ayudar a ralentizar o prevenir la aparición de la enfermedad de...

Preliminary Qualifications

  • 55-80 años de edad.
  • Memoria y pensamiento normales.
  • Menores de 64 años - Deben tener antecedentes familiares de enfermedad de Alzheimer.

“AHEAD” Alzheimer’s Prevention

If you're worried that your memory might start fading, then joining an Alzheimer's prevention study might be a great option for you. It might just help future generations too. This study examines whether a new drug may help to slow or prevent the onset of Alzheimer's disease in those with...

Preliminary Qualifications

  • 55-80 years of age.
  • Normal memory and thinking.
  • Under 64 years of age - Must have family history of Alzheimer's disease.

“Cassava” Alzheimer’s Trial

This trial aims to determine if a new, twice-a-day, oral drug called simufilam is safe and effective in slowing the progression of Alzheimer's disease.

Preliminary Qualifications

  • 50-87 years of age.
  • Have a gradual change in memory for 6 months or more.
  • Be diagnosed with, or have a suspected diagnosis of, Alzheimer's disease.

“CELIA” Alzheimer’s Trial

This study tests a new investigational medication for the treatment of Alzheimer's disease.  The drug is hoped to work by targeting and preventing the accumulation of tau tangles.

Preliminary Qualifications

  • 50-80 years of age.
  • Have mild cognitive impairment due to Alzheimer's disease, or mild Alzheimer's disease.

“Cerevel 002” Parkinson’s Disease Trial

We're testing an oral medication called Tavapadon as a possible treatment for Parkinson's disease over 35 weeks. Tavapadon aims to improve motor control symptoms.

Preliminary Qualifications

  • 40 years of age or older.
  • Have been diagnosed with Parkinson's disease within the last 3 years.

“Cerevel 003” Study for Parkinson’s Disease with Advanced Motor Fluctuations

In this study, we're looking at the use of an investigational drug called Tavapadon as adjunctive therapy for Parkinson's disease in people who are taking Levodopa and have motor fluctuations.

“Cognition” Study of Dementia with Lewy Bodies

This study looks at a new investigational medication to see if it will slow cognitive decline in individuals with Dementia with Lewy Bodies. The drug has been previously studied in 3 completed clinical trials and in 4 ongoing trials.

Preliminary Qualifications

  • 50-85 years of age.
  • Have a diagnosis of Dementia with Lewy Bodies.

“ENVISION” Alzheimer’s Trial

This study tests the FDA-approved medication Aduhelm. The trial is designed to verify the drug's efficacy in reducing amyloid plaques and slowing the rate of cognitive decline.

Preliminary Qualifications

  • 60-85 years of age.
  • Have experienced a progression of cognitive decline for 6 months or more.

“Gilead” NASH Study

This study looks at the efficacy of a combination therapy - in other words, using two different drugs together for the treatment of NASH.

Preliminary Qualifications

  • 18-80 years of age.
  • Diagnosed with cirrhosis of the liver due to NASH.

“Merck” Early Alzheimer’s Disease Trial

In this trial, an investigational drug is used to target tau proteins to reduce or stop their spread and slow the progression of Alzheimer's disease.

Preliminary Qualifications

  • 50-80 years of age.
  • Have mild cognitive impairment due to Alzheimer's disease, or mild or moderate Alzheimer's disease.

“Paradigm” Trial for Osteoarthritis of the Knee

This trial tests a new investigational drug intended for the treatment of knee pain due to osteoarthritis.

Preliminary Qualifications

  • 18 years of age or older.
  • Have osteoarthritis of the knee.

“Precision” NASH Biomarker Trial

This quick study is to collect blood samples from people with various stages of fatty liver disease or NASH to support advancements in medical diagnoses of diseases such as fatty liver disease and NASH.

Preliminary Qualifications

  • 18 years of age or older.

Sign Up

Free Memory Screens

We offer free memory screens for everyone. Memory screens are a great way to detect subtle changes in your thinking and enable early intervention, if needed.

If memory loss affects your daily life, if you’re simply concerned it might one day, or if you have a family history of Alzheimer's disease, then we’d love to assist you.

Simply fill out the form, and we’ll be in touch as soon as we can.

Sign up

One of our team members will contact you to schedule a time that works best with your schedule.

Your contact information

Preferred location

The best day and time for me is

This field is for validation purposes and should be left unchanged.